US Broker Ratings

Autolus Therapeutics (AUTL): A Biotech with a 545% Potential Upside – Investor Outlook

Autolus Therapeutics plc (NASDAQ: AUTL) is making waves in the biotechnology sector with its ambitious pipeline of T cell therapies aimed at treating cancer and autoimmune diseases. Based in London,..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 58.15% Upside in the Healthcare Space

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the specialty and generic drug manufacturing sector, has recently garnered attention in the investment community for its robust potential upside. With an..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 86.60% Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a healthcare sector player specializing in biotechnology, has been garnering attention in the investment community. Headquartered in Seattle, Washington, the company is making strides in..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 300% Upside in Biotech Investment

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotech sector, has captured investor attention with its ambitious approach to therapeutic innovation. Headquartered in Watertown, Massachusetts, this biotechnology company..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 58% Potential Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical device industry, has been capturing investor attention due to its promising potential upside of 58.33%. As a company operating..

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet with 90.86% Potential Upside

As the biopharmaceutical landscape continues to evolve, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) offers investors a compelling opportunity to engage with the future of brain health treatments. Headquartered in New..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a Challenging Market with Innovative Technologies

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, is a company that demands the attention of savvy investors. With a market capitalization of..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 751% Upside Potential in Biotech

Cel-Sci Corporation (NASDAQ: CVM) is capturing investor attention with its ambitious approach to cancer treatment and a staggering potential upside of 751.70%, according to analyst ratings. This clinical-stage biotechnology company,..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech with 94.53% Potential Upside

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is making waves in the biotechnology sector with its promising pipeline focused on central nervous system (CNS) disorders...

Simulations Plus, Inc. (SLP) Stock Analysis: Is There a 15% Upside for This Healthcare Innovator?

Simulations Plus, Inc. (NASDAQ: SLP), a prominent player in the healthcare sector, is making waves with its cutting-edge drug discovery and development software. Renowned for its use of artificial intelligence..

Oruka Therapeutics, Inc. (ORKA) Investor Outlook: Analyzing a 71% Potential Upside in Biotechnology

Oruka Therapeutics, Inc. (NASDAQ: ORKA) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. Specializing in the development of monoclonal antibody therapeutics for psoriasis and..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Innovative Solutions in Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) stands at the intersection of innovation and challenge within the medical devices sector. With a focus on performance coating technologies for intravascular devices and chemical components..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 75.60% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of medical instruments and supplies, particularly for treating peripheral vascular diseases and oncology...

LifeMD, Inc. (LFMD) Stock Analysis: A Potential Upside of 145% Amidst Growing Telehealth Demand

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving a niche in the rapidly expanding telehealth industry. With a market capitalization of $181.47 million, this New..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Player with Over 100% Upside Potential

Precigen, Inc. (NASDAQ: PGEN) is garnering attention in the biotechnology sector with a striking potential upside of over 100%. As a discovery and clinical-stage biopharmaceutical company, Precigen is making waves..

Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Promising 119% Potential Upside in the Biotech Sector

Prothena Corporation plc (NASDAQ: PRTA), an Irish biotechnology firm, has captured the attention of investors with its robust product pipeline targeting diseases caused by protein dysregulation. With a current market..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unveiling a 276% Potential Upside in the Biotech Arena

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its potential upside of 276.13%. This San Carlos, California-based company..

Auna SA (AUNA) Stock Analysis: Exploring a 90.63% Potential Upside in Healthcare

Investors seeking opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect, as its current market dynamics present a significant potential upside. Operating within the medical care..

OrthoPediatrics Corp. (KIDS) Stock Analysis: A Promising Growth in Pediatric Orthopedics with 28.94% Potential Upside

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector, is carving a niche in the medical devices industry by focusing on pediatric orthopedics. Headquartered in Warsaw, Indiana, this..

Semler Scientific, Inc. (SMLR) Stock Analysis: A Medical Device Innovator with 223% Potential Upside

Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its remarkable potential upside of 223%. This California-based..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds